Friday, November 10, 2023

The biggest milestone of 2023: Line 3 becomes a reality

Radek Fialka

Chief Business Officer

Recently, we reached one of the most significant milestones of this year when our Line 3 finally became an integral part of our building and cleanrooms. This milestone has been a focal point in the schedules of both Line 3 and central workplaces.

Line 3 is now in its final location, integrated into our cleanrooms. November will bring another challenge, which is the commissioning of the isolator and the joint regulation of cleanrooms and individual isolator modes. After Christmas, we will be prepared for comprehensive testing of individual components.

After Christmas, the OQ of cleanrooms will also be conducted, followed by an SAT of the line. After this phase, we will start getting ready for the moment when we can introduce our Line 3 to the State Institute for Drug Control. The year 2025 will bring a period for optimization, finalizing details, and preparing for commercial operation. We are full of expectations and excitement about what the coming year will bring!

If you want to take a glimpse into our future and see what our new line looks like, do not hesitate to check out the photo gallery. This year is incredibly exciting for us, and we are thrilled to invite you on this journey with us.

9. 12. 2025 | News

We attended an HR conference in Lyon, France

From 1–4 December, we took part in another edition of the global HR conference, which this year was held in Lyon.
read text
18. 11. 2025 | News

We have received the prestigious CDMO Leadership Awards Europe 2025

We have received the prestigious CDMO Leadership Awards Europe 2025 in the Small Molecule Dosage Form category. Only a handful of European companies made it among the award recipients – and we are proud to be one of them.
read text
6. 11. 2025 | News

We were at the CPHI 2025 trade fair in Frankfurt

At the end of October, we took part in CPHI 2025 in Frankfurt, one of the largest gatherings of professionals from across the pharmaceutical industry.
read text